Claessen, B.E.

stent lesion group vessel trial patient randomized rvd >2.65 mm stent thrombosis ll >13.4 mm ll <13.4 mm paclitaxel-eluting analysis spirit group c thrombosis outcome 2- year mace length paclitaxel-eluting stents study lesion length signi diameter everolimus-eluting paclitaxel-eluting stents jacc patients randomized ͻ0.01 table signi ficantly artery group b lesion complexity value everolimu angiographic event treatment restenosi rvd ͼ2.65 mm groups b boston scienti fic stent type 2- year rate intervention 2- year rates stent system result ef ficacy difference ll յ13.4 mm infarction revascularization xience claessen artery disease vessel size 2- year artery lesions signi ficant interaction drug-eluting cardiol rvd յ2.65 mm ll ͼ13.4 mm reference reference vessel diameter 2 years >13.4 <13.4 target <2.65 finite everolimus-eluting stents 3 groups id-tlr ficant second-generation fidence interval >2.65 complexity